Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Archimbaud

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
Leukemia Research|November 22, 2000
Dose-escalation study of single dose mitoxantrone in combination with timed sequential chemotherapy in patients with refractory or relapsing acute myelogenous leukemiaX Thomas, N Cambier, A L Taksin, et al.
Bone Marrow Transplantation|April 10, 1999
Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantationM Michallet, M C Perrin, A Belhabri, et al.
Annals of Internal Medicine|February 1, 1996
HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant RegistryM Michallet, E Archimbaud, G Bandini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literatureB Quesnel, H Kantarjian, J P Bjergaard, et al.
Cancer Treatment Reports|February 1, 1986
Intensive timed chemotherapy protocol for 37 resistant or relapsing acute myeloid leukemiasD Fière, L Campos, H V Van, et al.
Haematology and Blood Transfusion|January 1, 1987
Treatment of adult acute lymphoblastic leukemia. Preliminary results of a trial from the French GroupD Fière, E Archimbaud, J M Extra, et al.
Annals of Hematology|October 8, 2003
Prior and concurrent administration of recombinant human megakaryocyte growth and development factor in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia--a randomized, placebo-controlled, double-blind safety and efficacy studyK Geissler, J A Liu Yin, A Ganser, et al.
Hematology and Cell Therapy|April 1, 1996
Timed sequential chemotherapy for advanced acute myeloid leukemiaE Archimbaud, V Leblond, P Fenaux, et al.
Blood|November 26, 1999
A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as an adjunct to chemotherapy for adults with de novo acute myeloid leukemiaE Archimbaud, O G Ottmann, J A Yin, et al.
Leukemia|March 1, 1997
A randomized phase II study on the effects of 5-Aza-2'-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: an EORTC Leukemia Cooperative Group phase II study (06893)R Willemze, S Suciu, E Archimbaud, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Leukemia Research|November 22, 2000
Dose-escalation study of single dose mitoxantrone in combination with timed sequential chemotherapy in patients with refractory or relapsing acute myelogenous leukemiaX Thomas, N Cambier, A L Taksin, et al.
Bone Marrow Transplantation|April 10, 1999
Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantationM Michallet, M C Perrin, A Belhabri, et al.
Annals of Internal Medicine|February 1, 1996
HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant RegistryM Michallet, E Archimbaud, G Bandini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literatureB Quesnel, H Kantarjian, J P Bjergaard, et al.
Cancer Treatment Reports|February 1, 1986
Intensive timed chemotherapy protocol for 37 resistant or relapsing acute myeloid leukemiasD Fière, L Campos, H V Van, et al.
Haematology and Blood Transfusion|January 1, 1987
Treatment of adult acute lymphoblastic leukemia. Preliminary results of a trial from the French GroupD Fière, E Archimbaud, J M Extra, et al.
Annals of Hematology|October 8, 2003
Prior and concurrent administration of recombinant human megakaryocyte growth and development factor in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia--a randomized, placebo-controlled, double-blind safety and efficacy studyK Geissler, J A Liu Yin, A Ganser, et al.
Hematology and Cell Therapy|April 1, 1996
Timed sequential chemotherapy for advanced acute myeloid leukemiaE Archimbaud, V Leblond, P Fenaux, et al.
Blood|November 26, 1999
A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as an adjunct to chemotherapy for adults with de novo acute myeloid leukemiaE Archimbaud, O G Ottmann, J A Yin, et al.
Leukemia|March 1, 1997
A randomized phase II study on the effects of 5-Aza-2'-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: an EORTC Leukemia Cooperative Group phase II study (06893)R Willemze, S Suciu, E Archimbaud, et al.
Pageof 13